Navigation Links
PRoFESS(R) Results Announced at XVII European Stroke Conference
Date:5/14/2008

RIDGEFIELD, Conn., May 14 /PRNewswire/ -- Results of the PRoFESS(R) (Prevention Regimen For Effectively avoiding Second Strokes) trial -- the world's largest clinical research study for secondary stroke prevention -- were presented today at the XVII European Stroke Conference in Nice, France. In the study, recurrent stroke event rates for Aggrenox(R) and clopidogrel were similar (9.0% and 8.8%, respectively; HR 1.01, 95% CI 0.92-1.11). The study did not meet its primary endpoint of non-inferiority for AGGRENOX versus clopidogrel.(1)

In further exploratory analysis of the main secondary endpoint of the composite of stroke, myocardial infarction or vascular death, AGGRENOX and clopidogrel showed similar outcomes (13.1% versus 13.1%).(1)

In PRoFESS, the AGGRENOX arm had a higher number of hemorrhagic strokes compared to clopidogrel (0.8% and 0.4%, respectively) while ischemic stroke recurrences were less frequent in the AGGRENOX arm compared to the clopidogrel arm (7.7% and 7.9%, respectively).(1)

A post-hoc analysis showed comparable numbers of death and disabling strokes and a similar neurological outcome as measured by the modified Rankin Scale(2) at three months after the recurrent stroke and at the end of the PRoFESS trial between the two treatment arms.(1)

Major hemorrhagic events were observed more frequently in the AGGRENOX group compared with clopidogrel (4.1% versus 3.6%; HR 1.15, 95% CI 1.00-1.32). The benefit-risk ratio expressed as the combination of recurrent stroke and major hemorrhage was not significantly different between AGGRENOX and clopidogrel (11.7% and 11.4% respectively; HR 1.03, 95% CI 0.95-1.11).(1)

"Given the high prevalence of stroke and recurrent stroke in aging societies, physicians need a range of treatment options so they can offer patients a regimen tailored to their individual needs," said Professor Hans-Christoph Diener, MD, University of Essen, Germany, one of the three principal investigator
'/>"/>

SOURCE Boehringer Ingelheim Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. SPIRIT III Results Reaffirm Strong Performance of Boston Scientific PROMUS(TM) and TAXUS(R) Express(R) Stents
2. Alseres Pharmaceuticals Announces 12 Month Interim Results from the Phase I/IIa Cethrin(R) Clinical Trial in Acute Spinal Cord Injury
3. Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile
4. Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results
5. DATATRAK International Reports First Quarter Results for 2008
6. Results of the Phase III Pivotal Study of VYVANSE(TM) (Lisdexamfetamine Dimesylate) for the Treatment of ADHD in Adults Presented at National Scientific Meeting of Psychiatrists
7. Exelixis Announces First Quarter 2008 Financial Results
8. PEAK Surgical Announces Positive Results From Preclinical Study of PEAK PlasmaBlade(TM) for Obstetric and Gynecologic Surgery
9. Cadence Pharmaceuticals Reports First Quarter 2008 Financial Results and Provides Clinical Program Update
10. QRxPharma Releases Successful Phase 3 Study Results for Dual Opioid Pain Therapy
11. Senetek PLC Announces Positive Results from Pyratine-6(TM) Clinical Trial in Patients with Acne Rosacea
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2014)... -- UBM Medica US announces that ConsultantLive ... primary care clinicians offers a photo collection with authoritative ... a variety of summer scourges.  The ... of medical menaces: poison ivy, tick-borne infections, insect bites, ... covered on Consultantlive,s topic center that includes sun and ...
(Date:7/21/2014)... CORONA, Calif. , July 21, 2014 /PRNewswire/ ... a leader in automated retailing, micro-stores, custom vending ... interest in their automated medicine dispensing systems, which ... alternative heath clinics and marijuana dispensaries. AVT,s newly ... secure storage of medicines and regulated products. ...
(Date:7/21/2014)... 2014  Zacks.com announces the list of stocks featured in ... discuss the latest news and events impacting stocks and the ... Pharmaceuticals, Inc. (Nasdaq: ANTH - Free Report ), Amgen, ... and Company (NYSE: LLY - Free Report ), Actelion ... (Nasdaq: ITMN - Free Report ). Today, ...
Breaking Medicine Technology:ConsultantLive Presents Special Coverage of Summer Scourges 2ConsultantLive Presents Special Coverage of Summer Scourges 3Technology Driving Cannabis Industry 2The Zacks Analyst Blog Highlights: Anthera Pharmaceuticals, Amgen, Eli Lilly, Actelion and InterMune 2The Zacks Analyst Blog Highlights: Anthera Pharmaceuticals, Amgen, Eli Lilly, Actelion and InterMune 3The Zacks Analyst Blog Highlights: Anthera Pharmaceuticals, Amgen, Eli Lilly, Actelion and InterMune 4The Zacks Analyst Blog Highlights: Anthera Pharmaceuticals, Amgen, Eli Lilly, Actelion and InterMune 5The Zacks Analyst Blog Highlights: Anthera Pharmaceuticals, Amgen, Eli Lilly, Actelion and InterMune 6The Zacks Analyst Blog Highlights: Anthera Pharmaceuticals, Amgen, Eli Lilly, Actelion and InterMune 7
... The TandemHeart circulatory support system has been granted ... Contractor (MAC) serving over 1.3 million beneficiaries and over ... United States. "We are extremely pleased with ... TandemHeart system," said  Kraig McEwen, President and CEO of ...
... July 12, 2011 Projects In Knowledge ( www.projectsinknowledge.com ... information tools for busy clinicians, has just launched its ... offered online and soon as a free iPhone/iPad ... complexities of magnetic resonance imaging (MRI) and other imaging ...
Cached Medicine Technology:TandemHeart Approved for Expanded Reimbursement 2MedImage Cases™: A New Medical e-Textbook from Projects In Knowledge® 2MedImage Cases™: A New Medical e-Textbook from Projects In Knowledge® 3
(Date:7/22/2014)... 22, 2014) With over 170,000 students now ... exposed to injuries during practice and competition, according to ... Health and the Center for Injury Research and Policy ... study, published online today by The American Journal ... players experienced 1,406 injuries over the four academic years ...
(Date:7/22/2014)... Neck, N.Y. (PRWEB) July 22, 2014 Two ... and ADHD were significantly more abused as ... study noted that stimulant treatment for ADHD children ... dependence. However, the data did not reveal causation. , Since ... it is imperative to clarify the origins and best treatment ...
(Date:7/22/2014)... The physical demands of Crossfit are ... gymnastics, kettleball lifting, calisthenics, and strongman exercises are all ... co-owner of CrossFit East Cobb, Crossfit studio ... workouts like these require high quality supplementation. ... to take in about 160 grams of protein a ...
(Date:7/21/2014)... 22, 2014 MillionaireCasket.com, a well-known casket manufacturer ... maple caskets to its website. In addition to this, ... percent off) for all these brand new items. , ... provides great caskets for its current and prospective ... caskets, and oak caskets and more. According to the company’s ...
(Date:7/21/2014)... What do romance, sex, motherhood, literature, Martha’s ... can find them all in Thea Marsh's new book, ... lives on Martha’s Vineyard with her husband and three ... and becomes entangled in a steamy affair that threatens ... think about what choices they would make. Should Miranda ...
Breaking Medicine News(10 mins):Health News:High school lacrosse players at risk of concussions other injuries 2Health News:High school lacrosse players at risk of concussions other injuries 3Health News:New Studies Reporting a Higher Incidence of Child Abuse in ADHD and Dyslexia Suggest a Need for Early Medical Treatment, Notes Dr. Harold Levinson 2Health News:New Studies Reporting a Higher Incidence of Child Abuse in ADHD and Dyslexia Suggest a Need for Early Medical Treatment, Notes Dr. Harold Levinson 3Health News:New Studies Reporting a Higher Incidence of Child Abuse in ADHD and Dyslexia Suggest a Need for Early Medical Treatment, Notes Dr. Harold Levinson 4Health News:CrossFit East Cobb Fuels Their Intense Workouts with All-Natural EnergyFirst Supplements 2Health News:CrossFit East Cobb Fuels Their Intense Workouts with All-Natural EnergyFirst Supplements 3Health News:Cheap Maple Caskets Recently Added To China Casket Manufacturer MillionaireCasket.com’s Product Line 2Health News:Thea Marsh Releases Debut Novel that Celebrates and Reaches out to Women Everywhere 2
... allergic to animals like cats often do have a reaction ... it is possible to generate a new therapy based on ... ,A protein found in cat saliva and dander, called gamma ... to cats. The latest innovation aims to activate the antibody ...
... acupuncture and strengthening exercises may help relieve pelvic girdle ... study researchers divided 386 women into three groups. One ... and the third underwent standard treatment plus stabilizing exercise ... to record their pain levels every morning and evening ...
... have a greater risk of developing blood clots say researchers, ... taking the necessary steps to prevent the clots from forming. ... the doctors were aware of the risk of blood clots ... 40 percent of the doctors who were surveyed treated their ...
... of death and heart attack can be reduced for heart ... usual dose of an anti-clotting drug before the procedure is ... balloon-tipped catheter is threaded into an artery. The balloon is ... vessel. A small synthetic tube - stent is used to ...
... it is commonly known may be a treatment for life-threatening ... in 17 children. These children were treated with intravenous administration ... which is a common problem in LTA. , It ... treated with sodium bicarbonate there was a decrease in blood ...
... antioxidants present in the juice of pomegranate may help ... is the process of plaques etc forming in the ... causing a state of atherosclerosis. This causes disturbed blood ... stress increases the risk of atherogenesis. ,The ...
Cached Medicine News:
... base with vacuum stage, porous vacuum plate, reservoir ... instructions. The Model 785 vacuum blotter quickly ... agarose gel onto a nylon membrane. Because it ... nucleic acid samples can be separated on a ...
... regulator. The Model 785 vacuum blotter ... from an agarose gel onto a nylon ... min for transfer, the nucleic acid samples ... to a membrane, and the hybridization reaction ...
Inquire...
... proven electrophoretic transfer apparatus incorporating state-of-the-art plate electrodes ... allows for a very close positioning of the ... power source such as a battery charger, creates ... exceptionally rapid and exact electrophoretic transfer. ...
Medicine Products: